Frank Pallone actually said...
Biosimilars hold enormous potential to offer patients with serious and life-threatening diseases access to more treatment options and potentially lower cost options.
Context
Pallone emphasizes the benefits of biosimilars for patient access and cost reduction.
02/03/2016